Ebbert JO - Search Results

1

Varenicline for smoking cessation: efficacy, safety, and treatment recommendations.

Ebbert JO, Wyatt KD, Hays JT, Klee EW, Hurt RD. Ebbert JO, et al. Patient Prefer Adherence. 2010 Oct 5;4:355-62. doi: 10.2147/ppa.s10620. Patient Prefer Adherence. 2010. PMID: 21049087 Free PMC article.

2

Treatment of nicotine dependence.

Dale LC, Ebbert JO, Hays JT, Hurt RD. Dale LC, et al. Among authors: ebbert jo. Mayo Clin Proc. 2000 Dec;75(12):1311-6. doi: 10.4065/75.12.1311. Mayo Clin Proc. 2000. PMID: 11126841 Review.

3

Tobacco use outcomes of adolescents treated clinically for nicotine dependence.

Patten CA, Ames SC, Ebbert JO, Wolter TD, Hurt RD, Gauvin TR. Patten CA, et al. Among authors: ebbert jo. Arch Pediatr Adolesc Med. 2001 Jul;155(7):831-7. doi: 10.1001/archpedi.155.7.831. Arch Pediatr Adolesc Med. 2001. PMID: 11434853

4

Preventing lung cancer by stopping smoking.

Hurt RD, Ebbert JO. Hurt RD, et al. Among authors: ebbert jo. Clin Chest Med. 2002 Mar;23(1):27-36, vii. doi: 10.1016/s0272-5231(03)00074-1. Clin Chest Med. 2002. PMID: 11901917 Review.

5

Tobacco use outcomes among patients with lung cancer treated for nicotine dependence.

Sanderson Cox L, Patten CA, Ebbert JO, Drews AA, Croghan GA, Clark MM, Wolter TD, Decker PA, Hurt RD. Sanderson Cox L, et al. Among authors: ebbert jo. J Clin Oncol. 2002 Aug 15;20(16):3461-9. doi: 10.1200/JCO.2002.10.085. J Clin Oncol. 2002. PMID: 12177107

6

Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles.

Moyer TP, Charlson JR, Enger RJ, Dale LC, Ebbert JO, Schroeder DR, Hurt RD. Moyer TP, et al. Among authors: ebbert jo. Clin Chem. 2002 Sep;48(9):1460-71. Clin Chem. 2002. PMID: 12194923

7

Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study.

Dale LC, Ebbert JO, Schroeder DR, Croghan IT, Rasmussen DF, Trautman JA, Cox LS, Hurt RD. Dale LC, et al. Among authors: ebbert jo. Nicotine Tob Res. 2002 Aug;4(3):267-74. doi: 10.1080/14622200210153821. Nicotine Tob Res. 2002. PMID: 12215235 Clinical Trial.

8

Bupropion for the treatment of tobacco dependence: guidelines for balancing risks and benefits.

Hays JT, Ebbert JO. Hays JT, et al. Among authors: ebbert jo. CNS Drugs. 2003;17(2):71-83. doi: 10.2165/00023210-200317020-00001. CNS Drugs. 2003. PMID: 12521356 Review.

9

Bupropion sustained release for treatment of tobacco dependence.

Hays JT, Ebbert JO. Hays JT, et al. Among authors: ebbert jo. Mayo Clin Proc. 2003 Aug;78(8):1020-4; quiz 1024. doi: 10.4065/78.8.1020. Mayo Clin Proc. 2003. PMID: 12911050 Review.

10

Cotinine as a biomarker of systemic nicotine exposure in spit tobacco users.

Ebbert JO, Dale LC, Nirelli LM, Schroeder DR, Moyer TP, Hurt RD. Ebbert JO, et al. Addict Behav. 2004 Feb;29(2):349-55. doi: 10.1016/j.addbeh.2003.08.046. Addict Behav. 2004. PMID: 14732423

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters